PubRank

Allan D Kirk

Author PubWeight™ 80.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010 3.59
2 Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 2005 2.70
3 Composite tissue allotransplantation: development of a preclinical model in nonhuman primates. Transplantation 2005 2.08
4 Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis. Brain 2009 1.91
5 Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy. Lancet 2002 1.76
6 Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates. Nat Med 2009 1.76
7 APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors. Transplantation 2016 1.68
8 Composite tissue allotransplantation: classification of clinical acute skin rejection. Transplantation 2006 1.61
9 The impact of renal function on outcomes of bariatric surgery. J Am Soc Nephrol 2012 1.60
10 Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2002 1.48
11 LFA-1-specific therapy prolongs allograft survival in rhesus macaques. J Clin Invest 2010 1.41
12 Cutting edge: Rapamycin augments pathogen-specific but not graft-reactive CD8+ T cell responses. J Immunol 2010 1.38
13 Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005 1.25
14 Effect of donor factors on early graft survival in adult cadaveric renal transplantation. Am J Transplant 2002 1.19
15 Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. Transplantation 2002 1.14
16 IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates. Am J Transplant 2005 1.13
17 Induction immunosuppression. Transplantation 2006 1.10
18 Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154. J Clin Invest 2006 1.08
19 PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue. J Immunol 2008 1.07
20 A critical precursor frequency of donor-reactive CD4+ T cell help is required for CD8+ T cell-mediated CD28/CD154-independent rejection. J Immunol 2008 1.05
21 Objective, real-time, intraoperative assessment of renal perfusion using infrared imaging. Am J Transplant 2003 1.04
22 Induction of transplantation tolerance in non-human primate preclinical models. Philos Trans R Soc Lond B Biol Sci 2005 1.02
23 Memory T-cell-specific therapeutics in organ transplantation. Curr Opin Organ Transplant 2009 1.02
24 Human monocytes as intermediaries between allogeneic endothelial cells and allospecific T cells: a role for direct scavenger receptor-mediated endothelial membrane uptake in the initiation of alloimmunity. J Immunol 2006 0.99
25 LFA-1 blockade induces effector and regulatory T-cell enrichment in lymph nodes and synergizes with CTLA-4Ig to inhibit effector function. Blood 2011 0.98
26 Antigen-specific induced Foxp3+ regulatory T cells are generated following CD40/CD154 blockade. Proc Natl Acad Sci U S A 2011 0.97
27 Platelets deliver costimulatory signals to antigen-presenting cells: a potential bridge between injury and immune activation. Exp Hematol 2004 0.96
28 Studies investigating pretransplant donor-specific blood transfusion, rapamycin, and the CD154-specific antibody IDEC-131 in a nonhuman primate model of skin allotransplantation. J Immunol 2003 0.94
29 IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses. J Immunol 2009 0.93
30 Costimulation blockade: towards clinical application. Front Biosci 2008 0.93
31 The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge. Int Immunol 2004 0.93
32 In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial. Biol Blood Marrow Transplant 2013 0.93
33 Beyond histology: novel tools to diagnose allograft dysfunction. Clin J Am Soc Nephrol 2006 0.93
34 The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials. Transpl Immunol 2004 0.92
35 Recollective homeostasis and the immune consequences of peritransplant depletional induction therapy. Immunol Rev 2014 0.91
36 Donor-reactive T-cell stimulation history and precursor frequency: barriers to tolerance induction. Transplantation 2009 0.91
37 Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection. Hepatology 2012 0.91
38 Dynamics of human regulatory T cells in lung lavages of lung transplant recipients. Transplantation 2009 0.89
39 Non-invasive monitoring of tissue oxygenation during laparoscopic donor nephrectomy. BMC Surg 2008 0.88
40 Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model. Am J Transplant 2002 0.87
41 Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation. Transplantation 2002 0.87
42 Chemokines and their receptors in human renal allotransplantation. Transplantation 2011 0.87
43 Procedure Delegation by Attending Surgeons Performing Concurrent Operations in Academic Medical Centers: Balancing Safety and Efficiency. Ann Surg 2015 0.86
44 Surgical correction of gastroesophageal reflux in lung transplant patients is associated with decreased effector CD8 cells in lung lavages: a case series. Chest 2010 0.86
45 CD154 blockade, sirolimus, and donor-specific transfusion prevents renal allograft rejection in cynomolgus monkeys despite homeostatic T-cell activation. Transplantation 2007 0.86
46 Alemtuzumab. Transplantation 2007 0.86
47 Obesity following kidney transplantation and steroid avoidance immunosuppression. Clin Transplant 2008 0.86
48 Frontiers in nephrology: immune tolerance to allografts in humans. J Am Soc Nephrol 2007 0.85
49 Is tolerance induction the answer to adolescent non-adherence? Pediatr Transplant 2005 0.84
50 Humanized anti-CD154 antibody therapy for the treatment of allograft rejection in nonhuman primates. Transplantation 2002 0.84
51 Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. Kidney Int 2004 0.84
52 Successful renal transplantation in a patient with congenital generalized lipodystrophy: a case report. Am J Transplant 2004 0.83
53 Immune profiling: molecular monitoring in renal transplantation. Front Biosci 2003 0.82
54 Rabbit antithymocyte globulin induction and sirolimus monotherapy supports prolonged islet allograft function in a nonhuman primate islet transplantation model. Transplantation 2003 0.82
55 Composite tissue allotransplantation: classification of clinical acute skin rejection. Transplantation 2005 0.81
56 Differential effects of donor-specific alloantibody. Transplant Rev (Orlando) 2008 0.81
57 Transplant tolerance: converging on a moving target. Transplantation 2006 0.81
58 Precision Medicine for Critical Illness and Injury. Crit Care Med 2016 0.81
59 Idiopathic intracranial hypertension following kidney transplantation: a case report and review of the literature. Pediatr Transplant 2005 0.80
60 Location, location, location: regional immune mechanisms critically influence rejection. Nat Med 2002 0.80
61 Heterologous immunity triggered by a single, latent virus in Mus musculus: combined costimulation- and adhesion- blockade decrease rejection. PLoS One 2013 0.80
62 Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling. J Immunol 2010 0.80
63 Effects of combined treatment with CD25- and CD154-specific monoclonal antibodies in non-human primate allotransplantation. Am J Transplant 2003 0.80
64 Surgical transplant physical examination: correlation of renal resistance index and biopsy-proven chronic allograft nephropathy. J Am Coll Surg 2005 0.79
65 Associations of ABCB1 3435C>T and IL-10-1082G>A polymorphisms with long-term sirolimus dose requirements in renal transplant patients. Transplantation 2011 0.79
66 Tolerance: is it achievable in pediatric solid organ transplantation? Pediatr Clin North Am 2003 0.79
67 The role of alemtuzumab in facilitating maintenance immunosuppression minimization following solid organ transplantation. Transpl Immunol 2008 0.78
68 Islet cell xenotransplantation: a serious look toward the clinic. Xenotransplantation 2014 0.78
69 Intraoperative assessment of critical biliary structures with visible range/infrared image fusion. J Am Coll Surg 2007 0.78
70 Associations of ABCB1 and IL-10 genetic polymorphisms with sirolimus-induced dyslipidemia in renal transplant recipients. Transplantation 2012 0.77
71 High-frequency alloreactive T cells augment effector function of low-frequency CD8+ T-cell responses under CD28/CD154 blockade. Transplantation 2010 0.77
72 Primate models in organ transplantation. Cold Spring Harb Perspect Med 2013 0.77
73 Systems biological analyses reveal the hepatitis C virus (HCV)-specific regulation of hematopoietic development. Hepatology 2015 0.77
74 Workshop on late renal allograft dysfunction. Am J Transplant 2005 0.77
75 Assessment of critical renal ischemia with real-time infrared imaging. J Surg Res 2008 0.76
76 Less is more: maintenance minimization as a step toward tolerance. Am J Transplant 2003 0.76
77 Evaluation of tacrolimus abbreviated area-under-the-curve monitoring in renal transplant patients who are potentially at risk for adverse events. Clin Transplant 2010 0.75
78 Assessment of cadaveric organ viability during pulsatile perfusion using infrared imaging. Transplantation 2009 0.75
79 Nonhuman primates for the study of composite tissue allotransplantation. Transplantation 2007 0.75
80 Laparoscopic kidney donation: looking more than skin deep. Am J Transplant 2005 0.75
81 Delayed autotransplantation of a solitary kidney facilitated by pump perfusion preservation. Surgery 2003 0.75
82 Renal epithelial cell-derived monocyte colony stimulating factor as a local informant of renal injury and means of monocyte activation. Transpl Int 2009 0.75
83 Differential regulation of calcineurin isoforms in transplant patients: a new look at an old problem. Transplantation 2013 0.75
84 Challenges in therapeutic strategies for transplantation: where now from here? Transpl Immunol 2005 0.75
85 The clinical application of monoclonal antibody therapies in renal transplantation. Expert Opin Emerg Drugs 2004 0.75
86 Proposal for the American Journal of Transplantation policy for review of ethical standards of clinical research involving live human subjects. Am J Transplant 2005 0.75
87 Transplantation and autosomal recessive polycystic kidney disease. Nephrol News Issues 2010 0.75
88 Towards precision medicine: Accurate predictive modeling of infectious complications in combat casualties. J Trauma Acute Care Surg 2017 0.75
89 Human renal allograft rejection despite the absence of allogeneic passenger leukocytes. Am J Transplant 2004 0.75
90 Diagnostic tools for monitoring kidney transplant recipients. Semin Nephrol 2007 0.75